First-line treatment for metastatic kidney cancer – an interview with Dr Eric Jonasch
The following is an interview with Dr Eric Jonasch, Professor [...]
Adjuvant therapy in renal cell carcinoma: a review of the clinical trials to date
The number of drugs available to fight advanced renal cell carcinoma [...]
Adjuvant pazopanib shows no benefit for locally-advanced kidney cancer
Results from the phase 3 PROTECT clinical trial, which compared [...]
Type of long-term response to targeted therapy affects outcomes for advanced kidney cancer
A retrospective study conducted by researchers in the Czech Republic [...]
Novel treatment options for kidney cancer presented at ASCO 2017
The following video is an interview between PracticeUpdate and Dr Bradley [...]
Adjuvant pazopanib reduces risk of recurrence after nephrectomy in people with locally advanced kidney cancer
Results from the PROTECT clinical trial, a phase III trial [...]
Pazopanib for the treatment of von Hippel-Lindau disease
The results from a phase II clinical trial, which demonstrates [...]
Neoadjuvant and adjuvant therapy for kidney cancer
A comprehensive review of neoadjuvant therapy and adjuvant therapy for [...]
Pazopanib before surgery is safe for metastatic kidney cancer
A recent study reported in the journal JAMA Oncology and conducted [...]
